Clinicopathological Characteristics of Non-small Cell Lung Cancer Patients With Primary Concomitant EGFR T790M Mutation

被引:0
|
作者
Li, Hang [1 ]
Wang, Rui [1 ]
Hu, Haichuan [1 ]
Pan, Yunjian [1 ]
Wang, Lei [1 ]
Zhang, Yang [1 ]
Sun, Yihua [1 ]
Chen, Haiquan [1 ]
机构
[1] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
关键词
D O I
10.1378/chest.1830238
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
350A
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
    Li, Hang
    Hu, Haichuan
    Wang, Rui
    Pan, Yunjian
    Wang, Lei
    Li, Yuan
    Zhang, Yang
    Ye, Ting
    Zhang, Yiliang
    Li, Bin
    Shen, Lei
    Sun, Yihua
    Chen, Haiquan
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 513 - 524
  • [2] Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation
    Wang, Shuyuan
    Yan, Bo
    Zhang, Yanwei
    Xu, Jianlin
    Qiao, Rong
    Dong, Yu
    Zhang, Bo
    Zhao, Yiming
    Zhang, Lele
    Qian, Jie
    Lu, Jun
    Zhao, Ruiying
    Han, Baohui
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2880 - 2886
  • [3] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [4] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [5] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
    Prim, Nathalie
    Quoix, Elisabeth
    Beau-Faller, Michele
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
  • [6] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [7] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [8] Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
    Lee, J. C.
    Yang, S.
    Oh, D. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S806 - S807
  • [9] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
    Jenkins, Suzanne
    Yang, James C-H.
    Ramalingam, Suresh S.
    Yu, Karen
    Patel, Sabina
    Weston, Susie
    Hodge, Rachel
    Cantarini, Mireille
    Janne, Pasi A.
    Mitsudomi, Tetsuya
    Goss, Glenwood D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
  • [10] Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Kyeong Yeon
    Kim, Chi Young
    Lee, Sang Hoon
    Heo, Seok-Jae
    Chang, Yoon Soo
    Kim, Eun Young
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14